Originator Organization Abdera Therapeutics, Inc.Startup |
Active Organization Abdera Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | - | Abdera Therapeutics, Inc.Startup | 29 Feb 2024 |